Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H29NO.ClH |
Molecular Weight | 323.901 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC(CCN1CCCCC1)(C2CCCC2)C3=CC=CC=C3
InChI
InChIKey=WBCWFMFZMRFRLT-UHFFFAOYSA-N
InChI=1S/C19H29NO.ClH/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20;/h1,3-4,9-10,18,21H,2,5-8,11-16H2;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C19H29NO |
Molecular Weight | 287.4397 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
CYCRIMINE is an antispasmodic drug used for the treatment of Parkinson's disease (PD). It binds the muscarinic acetylcholine receptor M1, effectively reducing levels of acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of PD.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P11229 Gene ID: 1128.0 Gene Symbol: CHRM1 Target Organism: Homo sapiens (Human) Sources: http://www.druglib.com/activeingredient/cycrimine/ |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Pagitane Approved UseCycrimine is used for Parkinson's disease. Launch Date1952 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:32:07 GMT 2023
by
admin
on
Fri Dec 15 16:32:07 GMT 2023
|
Record UNII |
9RB4L4K895
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
||
|
NCI_THESAURUS |
C38149
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1201227
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
9RB4L4K895
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
59693
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
101597
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
DBSALT000820
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
100000084675
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
C65360
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
126-02-3
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
204-764-8
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
SUB01530MIG
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
169452
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | |||
|
m136
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
235421
Created by
admin on Fri Dec 15 16:32:07 GMT 2023 , Edited by admin on Fri Dec 15 16:32:07 GMT 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |